Professional
Added to YB: 2024-10-01
Pitch date: 2024-08-08
DXCM [bullish]
DexCom, Inc.
-6.43%
current return
Author Info
No bio for this author
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
Market Cap
$23.5B
Pitch Price
$71.56
Price Target
N/A
Dividend
N/A
EV/EBITDA
21.49
P/E
33.52
EV/Sales
5.04
Sector
Health Care Equipment and Supplies
Category
N/A
TCW Select Equities Fund Portfolio Holding: DexCom, Inc.
DXCM: Shares down on Stelo launch concerns. Mgmt's $40M 2024 sales est. for OTC 15-day CGM may be conservative. Thesis intact: strong product advantage in expanding market. Weakest performer in healthcare/consumer discretionary, but remain constructive despite volatility.
Read full article (1 min)